SNC-Lavalin Group Inc. (TSE:ATR – Free Report) – Analysts at Raymond James Financial lifted their Q3 2025 EPS estimates for SNC-Lavalin Group in a research report issued on Friday, August 8th. Raymond James Financial analyst F. Bastien now anticipates that the company will post earnings of $0.88 per share for the quarter, up from their prior estimate of $0.84. Raymond James Financial also issued estimates for SNC-Lavalin Group’s Q1 2026 earnings at $0.85 EPS, Q2 2026 earnings at $0.90 EPS, Q3 2026 earnings at $1.12 EPS and Q4 2026 earnings at $1.13 EPS.
Separately, National Bank Financial downgraded shares of SNC-Lavalin Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, June 11th.
SNC-Lavalin Group Price Performance
About SNC-Lavalin Group
AptarGroup, Inc provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage.
Featured Stories
- Five stocks we like better than SNC-Lavalin Group
- How to Invest in the FAANG Stocks
- MNDY Stock Has a Case of the Mondays—Buy Before the Rebound
- Stock Analyst Ratings and Canadian Analyst Ratings
- IPO Market Stays Hot With These 2 Debuting Stocks
- How to Calculate Options Profits
- Taiwan Semiconductor Stock: Own It, Don’t Trade It
Receive News & Ratings for SNC-Lavalin Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SNC-Lavalin Group and related companies with MarketBeat.com's FREE daily email newsletter.
